Právní předpis byl sestaven k datu 23.11.2024.
Zobrazené znění právního předpisu je účinné od 19.12.2012.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2013
420/2012 Sb.
420
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 22. xxxxxxxxx 2012
x xxxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2013
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 písm. e) xxxxxx č. 258/2000 Xx., o ochraně xxxxxxxxx zdraví x x xxxxx xxxxxxxxx xxxxxxxxxxxxx zákonů, xx xxxxx xxxxxxxxxx předpisů, xxxxxxx na xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2013:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX):
Xxxxxxxxx anatoxinum
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx externae proteinum
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx typus 1
Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx phosphas Xxxxxxxxxxx xxxxxxxxxx x, Tetani xxxxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx (DTaP):
Xxxxxxxxxxx xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx jednotek
Xxxxxx xxxxxxxxxx ≥ 40 mezinárodních xxxxxxxx
Xxxxxxxxx anatoxinum (XX) 25 mikrogramů
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum (XXX) 25 mikrogramů
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, nákazám xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
Xxxxxxxxxxx xxxxxxxxxx | xxx. 30 mezinárodních xxxxxxxx |
Tetani anatoxinum | xxx. 40 mezinárodních xxxxxxxx |
Xxxxxxxxx xxxxxxxxxx (XX) | 25 xxxxxxxxxx |
Xxxxxxxxx haemaglutininum filamentosum (XXX) | 25 xxxxxxxxxx |
Xxxxxxxxxxx (69kD) | 8 xxxxxxxxxx |
Xxxxxxxxxxx xxxxxxxxxx X | 10 xxxxxxxxxx |
xxx xxxxxxxxx tetanico | 20-40 xxxxxxxxxx |
1d) xxxxxxxx xxxxx xxxxx xxxxxxx a xxxxxx - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx ... xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx xxxxxxxxxxx ... min. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx tetanico (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx proti xxxxxx:
Xxxxxx anatoxinum ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1g) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X v xxxxxxx xxxxxxx:
Antigenum xxxxxxxxx xxxxxxxxxxx X
1ch) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx (Schwarz) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu50
Xxxxxxxxxxx virus xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
Xxxxxxxx virus attenuatum (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50
1i) očkovací xxxxx proti xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ... 8 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ... 32 antigenních X xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx imunochemické metody.
1x) xxxxxxxx látka xxxxx nákazám vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx formuli:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx typus:
1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10A, 11A, 12X, 14, 15X, 17X, 18C, 19X, 19X, 20, 22X, 23X, 33X ... 25 mikrogramů z xxxxxxx xxxxxxxx
1x) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Pneumococcale polysaccharidum xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 19X
Pneumococcale xxxxxxxxxxxxxxx sérotypus 19F
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx):
Diphtheriae anatoxinum | xx xxxx xxx 2 xxxxxxxxxxx jednotky |
Xxxxxx xxxxxxxxxx | ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx |
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum | 8 xxxxxxxxxx |
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx | 8 xxxxxxxxxx |
Xxxxxxxxx | 2,5 xxxxxxxxxx |
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx) | 40 X jednotek xxxxxxxx |
xxxxx 2 (xxxx XXX-1) | 8 D xxxxxxxx antigenu |
typus 3 (xxxx Xxxxxxx) | 32 X jednotek xxxxxxxx |
XXXX
1lb) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Difterický xxxxxx | více nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx) |
Xxxxxxxxx xxxxxx | xxxx xxxx rovno 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx) |
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxx | 2,5 xxxxxxxxxx |
Xxxxxxxxxxxx hemaglutinin | 5 mikrogramů |
Xxxxxxx xxxx 2+3 | 5 xxxxxxxxxx |
Pertaktin | 3 xxxxxxxxxx |
Xxxxx poliomyelitis xxxx 1 (xxxxxxxxxxxx) | 40 xxxxxxxxxxx X xxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) | 8 xxxxxxxxxxx D xxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) | 32 xxxxxxxxxxx D xxxxxxxx |
1x) očkovací xxxxx xxxxx tuberkulóze:
Xxxxxxxx Calmette Guérin (xxxxxxxxxx) 100 000 - 300&xxxx;000 X.X.*
(xxxx Xxxxxxxxxx 1331)
*X.X. = xxxx xxxxxxx
1x) xxxxxxxx látka xxxxx virové hepatitidě X pro xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Antigenum xxxxxxxxx xxxxxxxxxxx B biosyntheticum 20 xxxxxxxxxx; adjuvans XX04X obsahující 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx v 1 xxxxx
2. Antigenní xxxxxxx xxxxxxxxxx látek xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Xxxxxxxxx tegiminis xxxxxxxxxxx X
2x) xxxxxxxx xxxxx proti xxxxxxxxx
Xxxxx xxxxxx inactivatum (xxxx Xxxxxx xxxxxx XX/XX 38 1503-3M více xxxx xxxxx 2,5 xxxxxxxxxxxxx jednotek x 1 xxxxx (0,5 xx)
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
Ministr:
xxx. XXXx. Heger, CSc., x. r.
Xxxxxxxxx
Xxxxxx předpis č. 420/2012 Sb. xxxxx xxxxxxxxx dnem 19.12.2012.
Xx xxx xxxxxxxx právní předpis xxxxx xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx právních norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.